Metal‐Free Peroxidase‐Mimetic Nanocatalysts for Chemodynamic Vascular‐Disrupting Cancer Therapy
Advanced Healthcare Materials · 2023
DOI: 10.1002/adhm.202301306 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Healthcare Materials, 2023. Verfasst von Zihao Sun und 5 weiteren Autor:innen. Beteiligte Einrichtung: Beijing National Laboratory for Molecular Sciences, Key Laboratory of Molecular Nanostructure and Nanotechnology, CAS Research/Education Center for E…. Hauptthemen laut MEDLINE: Neoplasms, Cardiovascular Diseases. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 31 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Chinese Academy of Sciences.
Abstract (Originalsprache)
Metal ion‐facilitated chemodynamic therapy (CDT) is an emerging method for treating cancer. However, its potential is hindered by its low catalytic performance in weakly acidic tumor microenvironments (TMEs) and the severe toxicity of free metal ions. A new approach to tumor therapy, chemodynamic vascular disruption (CVD), is introduced using metal‐free, peroxidase (POD)‐mimetic multihydroxylated [70] fullerene (MHF) nanocatalysts. The research shows that MHF contains C···O active sites, as demonstrated by density functional theory (DFT) calculations, and converts H 2 O 2 into ∙OH across a pH range of 6.0–10.0. The generation of ∙OH and the dismantling of tumor blood vessels are observed in real‐time using mouse dorsal skin‐fold chamber (DSFC) models. Applying proteomics, it is discovered that the CVD mechanism involves the nanocatalytic MHF enhancing H 2 O 2 decomposition in the TME, producing ∙OH. This damages tumor vascular endothelial junction proteins, causing vascular leakage and subsequently cutting off the vascular supply to the tumor cells. This method deviates from the traditional CDT that targets tumor cells. Instead, the proficient MHF nanocatalysts aim to directly disrupt the tumor vasculature, enhancing anti‐tumor efficiency without triggering harmful toxicity. The proposed CVD therapeutic strategy enhances the application of gentle carbon nanocatalysts in cancer therapy, offering new perspectives on nanocatalytic medicine.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Beijing National Laboratory for Molecular Sciences, Key Laboratory of Molecular Nanostructure and Nanotechnology, CAS Research/Education Center for Excellence in Molecular Sciences, Institution Institute of Chemistry, C…
- Department of Chemical Sciences, University of Chinese Academy of Sciences, Beijing, 100049, China.
ORCID-Profile: Chunru Wang
Förderung
- National Natural Science Foundation of China
- Chinese Academy of Sciences
Zitieren
APA
Sun, Z., Zhou, C., Zhou, Y., Su, S., Wang, C., & Zhen, M. (2023). Metal‐Free Peroxidase‐Mimetic Nanocatalysts for Chemodynamic Vascular‐Disrupting Cancer Therapy. Advanced Healthcare Materials. https://doi.org/10.1002/adhm.202301306
Vancouver
Sun Z, Zhou C, Zhou Y, Su S, Wang C, Zhen M. Metal‐Free Peroxidase‐Mimetic Nanocatalysts for Chemodynamic Vascular‐Disrupting Cancer Therapy. Advanced Healthcare Materials. 2023. doi:10.1002/adhm.202301306
BibTeX
@article{Sun2023,
author = {Sun, Zihao and Zhou, Chen and Zhou, Yue and Su, Shenge and Wang, Chunru and Zhen, Mingming},
title = {Metal‐Free Peroxidase‐Mimetic Nanocatalysts for Chemodynamic Vascular‐Disrupting Cancer Therapy},
journal = {Advanced Healthcare Materials},
year = {2023},
doi = {10.1002/adhm.202301306}
}
EUVIMED